Skip to main content
OpenTrials
Completed

NCT Number: NCT00199654

Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III

The follow up of colorectal cancer after curative surgery has to find loco-regional relapses or synchronous metastases, and to detect adenomas and new cancer on the rest of the colon.

The increase of survival after relapse of the colorectal cancer depends on the possibility of curative action or after chemotherapy response.

This is a Phase III open-labeled, multicenter, multidisciplinary, randomised study, comparing 2 arms of 188 patients (i.e. 376 total patients).

Study Period (date of first inclusion/last inclusion): 3 years.

Follow Up: 3 years.

The primary objective is the evaluation of PET performance in the earlier relapse detection of the colorectal cancer relapse in comparison with conventional control (including carcinoembryonic [CEA] levels and other classic radiological exams).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colorectal Cancer Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Rectal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Cancérologie et Hépato-Gastro-Entérologie, Bordeaux, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed and dated written informed consent
  • Confirmed stage II or III (TNM)
  • Patient with curative surgery for colorectal adenocarcinoma
  • Total digestive endoscopy prior or post surgery.
  • Age > 18 years old
  • Normal liver ultrasound and chest X-ray or thoraco-abdomino pelvic computed tomography (CT) scan.
  • In fertile women, efficient contraception or postmenopausal patient (amenorrhea for at least 1 year)

Exclusion criteria

  • Serious concomitant pathology
  • Uncontrolled diabetes with a classical treatment (glycaemia >1.4 g/l)
  • Other malignant tumour within the last 5 years (except for curatively treated basocellular carcinoma of the skin or in situ cervical carcinoma).
  • Uncontrolled infection
  • Women who are pregnant or lactating
  • Inability to understand informed consent
  • Psychological or geographic impossibility to follow up for three years.

Treatment and study plan

PET

Procedure

Primary outcomes

  1. Time to colorectal cancer relapse

Secondary outcomes

  1. Evaluation of overall survival in the two groups

    Time frame: after curative resection of colorectal cancer stage II or III

  2. Evaluation of the rate of curative surgery

    Time frame: after relapse

  3. Comparison of the medical cost in the two detection strategies

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

University Hospital, Limoges

Other

Registry information

Official study title

PET Interest in the Follow Up of Colorectal Cancer Stage II and III: Phase III Randomised Study

Important dates

Study start
2004
Primary completion
2012
Study completion
2013
First posted
Sep 20, 2005
Registry last updated
Apr 9, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.